Početna › Bubrežna insuficijencija › Florida
Kliničke studije za Bubrežna insuficijencija u državi Florida
14 studija za Bubrežna insuficijencija traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
- Kailera Clinical Site, Orlando
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 85 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07793929A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- Cleveland Clinic Weston Hospital, Weston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05805709A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
- Floridian Clinical Research, LLC ( Site 0001), Miami Lakes
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 80 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07734610Product Surveillance Registry
- Bradenton
- Clearwater
- Davie
- i još 7
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 18. ruj 2026. · NCT01524276A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
- Panax Clinical Research, LLC, Miami Lakes
- GCP Research - Florida, St. Petersburg
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 85 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07741604Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- D&H Doral Research Center, Doral
- AGA Clinical Trials, Hialeah
- Convenient Medical Center, Hialeah
- i još 13
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07271186Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin
- Research Site, Orlando
U tijeku regrutacijaFaza 1
Od 18 do 80 godina · Oba spola · Ažurirano 4. ruj 2026. · NCT07754331SPYRAL GEMINI Pilot Study
- Orlando Health Heart & Vascular Institute, Orlando
- BayCare Health System Mease Countryside Hospital, Safety Harbor
U tijeku regrutacija
Od 18 do 80 godina · Oba spola · Ažurirano 24. lip 2026. · NCT06907147A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
- Floridian Clinical Research, Miami Lakes
- Orlando Clinical Research Center, Orlando
U tijeku regrutacijaFaza 1
Od 18 do 85 godina · Oba spola · Ažurirano 16. lip 2026. · NCT07559396A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
- Orlando Clinical Research Center, Orlando
- Genesis Clinical Research, LLC, Tampa
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 80 godina · Oba spola · Ažurirano 12. svi 2026. · NCT07315360Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
- Cleveland Clinic Florida, Weston
U tijeku regrutacija
Od 22 do 85 godina · Oba spola · Ažurirano 19. ožu 2026. · NCT07017933SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Tallahassee Research Institute, Tallahassee
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 17. velj 2026. · NCT06001827Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
- Mayo Clinic, Jacksonville
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 28. sij 2026. · NCT06752577A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Sarasota Memorial Hospital, Sarasota
- University of South Florida, Tampa
U tijeku regrutacija
Od 18 do 90 godina · Oba spola · Ažurirano 22. pro 2025. · NCT04671771Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.